Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Oncofertility w praktyce klin.
  • Obniżka

Photodynamic Therapy of Ocular Diseases

9780781734462
504,00 zł
453,60 zł Zniżka 50,40 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 453,60 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
This unique text, authored by the individuals who pioneered the use of Photodynamic Therapy (PDT), is designed to provide clinicians with an understanding of the basic physics of PDT and the rationale and techniques of PDT in ophthalmology and especially in age-related macular degeneration. The different photosensitizers, lasers, and possible future use of this new therapeutic modality for other intraocular pathologies are also discussed. This text offers a step-by-step, detailed approach to the use of PDT, picking up where the scientific journal articles leave off.
Szczegóły produktu
Lippincott Williams & Wilkins
38581
9780781734462
9780781734462

Opis

Rok wydania
2003
Numer wydania
1
Oprawa
twarda
Liczba stron
309
Wymiary (mm)
216 x 279
Waga (g)
1048

  • SECTION I:: INTRODUCTION TO PHOTODYNAMIC THERAPY 1

  • History of Photodynamic Therapy for Ocular Disorders 1
    Joan W. Miller and Evangelos S. Gragoudas
  • Principles of Photodynamic Therapy 11
    Hubert Erik van den Bergh and J.P. Ballini

    SECTION II:: PRECLINICAL STUDIES 43

  • In Vitro Assessment and Bioassay of Photosensitizers for Ocular Photodynamic Therapy 43
    Reem Z. Renno, Yoshiko Terada, Evangelos S. Gragoudas, and Joan W. Miller
  • Combination of Photodynamic Therapy and Antiangiogenic Agents 53
    Reem Z. Renno, Yoshiko Terada, Evangelos S. Gragoudas, and Joan W. Miller
  • Verteporfin PDT for Experimental Choroidal Neovascularization 63
    Joan W. Miller and Evangelos S. Gragoudas
  • Photodynamic Therapy for Experimental Choroidal Neovascularization Using ATX-S10(Na) 73
    Akira Obana
  • Photodynamic Therapy for Experimental Choroidal Neovascularization Using Purlytin 85
    Darius M. Moshfeghi and Gholam A. Peyman
  • Photodynamic Therapy for Experimental Choroidal Neovascularization Using Lu-Tex 89
    J. Daniel Arbour and Danny Gauthier
  • Photodynamic Therapy for Iris Neovascularization 99
    Deeba Husain, Joan W. Miller, and Evangelos S. Gragoudas
  • Recovery After Repeated Photodynamic Therapy Treatments for Normal Retina and Choroid 107
    Martin H. Reinke, Evangelos S. Gragoudas, and Joan W. Miller
  • The Ocular Localization of Photosensitizers 119
    Sean Koh and Robert Haimovici
  • Photodynamic Therapy of Experimental Choroidal Neovascularization Using NPe6 129
    Shin Yoneya, Darius M. Moshfeghi, and Gholam A. Peyman
  • Photodynamic Therapy for Experimental Intraocular Tumors 135
    Rosa Y. Kim and Lucy H. Y. Young

    SECTION III:: CLINICAL STUDIES 139

  • Verteporfin Photodynamic Therapy for Age- Related Macular Degeneration 139
    Part 1. Verteporfin Photodynamic Therapy for Age-Related Macular Degeneration:: How To Do It 139
    René-Pierre Copt and Leonidas Zografos
    Part 2. Fluorescein Angiography and Optical Coherence Tomography in Photodynamic Therapy for Choroidal Neovascularization Caused by Age-Related Macular Degeneration 143
    Gisèle Soubrane and Gabriel Coscas
    Part 3. Indocyanine Green Angiography in Photodynamic Therapy of Choroidal Neovascularization 156
    Antonio P. Ciardella, Jason S. Slakter, and Lawrence A. Yannuzzi
    Part 4. Subfoveal Choroidal Blood Flow and Its Regulation After Verteporfin Photodynamic Therapy in Choroidal Neovascularization 164
    Constantin J. Pournaras, Charles E. Riva, Eric Logean, and Gisèle Soubrane
    Part 5. Results of Age-Related Macular Degeneration Trials Using Verteporfin PDT:: Phases I and II 172
    Joan W. Miller and Evangelos S. Gragoudas
    Part 6. Results of Age-Related Macular Degeneration Trials Using Verteporfin PDT (Visudyne):: the Treatment of Age- Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Trials 181
    Jennifer Joan Arnold
  • Verteporfin Photodynamic Therapy in Pathologic Myopia 197
    Jordi M. Monés
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów